Related references
Note: Only part of the references are listed.ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation
Koji Kase et al.
CARCINOGENESIS (2021)
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
Hiroshi Nakano et al.
SCIENTIFIC REPORTS (2021)
Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report
Ken Miyabe et al.
BMC GASTROENTEROLOGY (2021)
Thirty years of Epstein-Barr virus-associated gastric carcinoma
Masashi Fukayama et al.
VIRCHOWS ARCHIV (2020)
MiR-BART1-5p targets core 2β-1,6-acetylglucosaminyltransferase GCNT3 to inhibit cell proliferation and migration in EBV-associated gastric cancer
Juanjuan Liu et al.
VIROLOGY (2020)
Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer
Jae Hee Yoon et al.
MICROORGANISMS (2020)
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis
Dan Wang et al.
FASEB JOURNAL (2020)
Heterogeneity of ARID1A expression in gastric cancer may affect patient survival and therapeutic efficacy
Motonobu Saito et al.
HUMAN PATHOLOGY (2020)
EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1
Yingfen Wu et al.
FASEB JOURNAL (2020)
EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway
Min Dong et al.
CELLULAR ONCOLOGY (2020)
Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer
Yali Song et al.
VIROLOGY (2020)
Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2
Kyoungmi Min et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer
Jia Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
Hui Cai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
Miao Xu et al.
NATURE GENETICS (2019)
Prognostic role of ARID1A negative expression in gastric cancer
Mai Ashizawa et al.
SCIENTIFIC REPORTS (2019)
Epstein-Barr Virus and Innate Immunity: Friends or Foes?
Sonia Jangra et al.
MICROORGANISMS (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2
Alexandre S. Cristino et al.
BLOOD (2019)
Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer
Young-Bae Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients
Julia Maria Tober et al.
HUMAN PATHOLOGY (2019)
EBV miR-BART10-3p Promotes Cell Proliferation and Migration by Targeting DKK1
Kyoungmi Min et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Yang Liu et al.
CANCER CELL (2018)
Analysis of DNA methylation in cancer: location revisited
Alexander Koch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression
Xiang Zheng et al.
JOURNAL OF VIROLOGY (2018)
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Kousaku Mimura et al.
CANCER SCIENCE (2018)
Non-coding RNA networks in cancer
Eleni Anastasiadou et al.
NATURE REVIEWS CANCER (2018)
The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis
Brigid Chiyoko Poling et al.
VIROLOGY (2017)
The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus
Jinlin Li et al.
PLOS PATHOGENS (2017)
The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis
Y. F. Wang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
J. Ma et al.
LEUKEMIA (2016)
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103
Baoyu He et al.
CELL DEATH & DISEASE (2016)
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
Chris T. Williamson et al.
NATURE COMMUNICATIONS (2016)
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1
Yali Song et al.
ONCOTARGET (2016)
Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
Guang-Nian Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD
Hyoji Kim et al.
CANCER LETTERS (2015)
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing
Masataka Takenaka et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Update on Epstein-Barr virus and gastric cancer
Aya Shinozaki-Ushiku et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Jianfeng Shen et al.
CANCER DISCOVERY (2015)
Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma
Margaret L. Gulley
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment
Kousaku Mimura et al.
CANCER SCIENCE (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Epstein-Barr Virus-Encoded MicroRNA BART15-3p Promotes Cell Apoptosis Partially by Targeting BRUCE
Hoyun Choi et al.
JOURNAL OF VIROLOGY (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
Epstein Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
Aditi Sengupta Banerjee et al.
VIROLOGY (2013)
Epstein-Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
Atsushi Kaneda et al.
CANCER RESEARCH (2012)
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Rebecca L. Skalsky et al.
PLOS PATHOGENS (2012)
Classification of Epstein-Barr Virus-Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes
Keisuke Matsusaka et al.
CANCER RESEARCH (2011)
The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non-Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
Motonobu Saito et al.
CLINICAL CANCER RESEARCH (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma
Aya Shinozaki et al.
CANCER RESEARCH (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3
Tianli Xia et al.
CANCER RESEARCH (2008)
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival
Elizabeth Yee-Wai Choy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Expression of viral MicroRNAs in Epstein-Barr virus-associated gastric carcinoma
Do Nyun Kim et al.
JOURNAL OF VIROLOGY (2007)
Share Paper
